DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

SunTrust Robinson Humphrey Maintains Hold on Sage Therapeutics, Lowers Price Target to $50

SunTrust Robinson Humphrey maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and lowers the price target from $60 to $50.

Benzinga · 02/28/2020 14:20

SunTrust Robinson Humphrey maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and lowers the price target from $60 to $50.